Vlasov A P, Trofimov V A, Vlasova T I, Markin O V, Sheyranov N S, Fedoseeva T A, Kolesov A V
Ogarev National Research Mordovia State University, Saransk, Russia.
Georgievsk Regional Hospital, Georgievsk, Russia.
Khirurgiia (Mosk). 2021(8):20-27. doi: 10.17116/hirurgia202108120.
To establish the universality and regularity of hepatic disorders, their role in pathogenesis of homeostasis impairment and determine scientific base for a new syndrome - hepatic distress syndrome in surgery.
Chronic experiments on outbred dogs were carried out. Acute peritonitis was simulated in the first group (=15), acute destructive pancreatitis in the second group (=15), acute obstructive intestinal obstruction in the third group (15). In the fourth group, experimental acute peritonitis (=15) was followed by Remaxol infusions (20 ml/kg). Liver function was evaluated using the indicators of endogenous intoxication, lipid metabolism markers, as well as composition of lipids in liver tissue. Clinical studies included 44 patients with peritonitis (the first subgroup - standard therapy (=20), Remaxol infusion in the second subgroup (=24), severe acute pancreatitis (=18), acute adhesive intestinal obstruction (=20)). Patients underwent surgery. Along with routine indicators, we analyzed severity of endogenous intoxication, lipid peroxidation, phospholipase activity, serum lipids and red blood cell count.
Experimental and clinical studies have shown significant liver damage in all diseases with various pathogenesis. Regardless of urgent disease, one of the leading component is membrane-destabilizing process. The last one is determined by excessive activity of membrane lipid peroxidation and phospholipases in liver tissue. Severe abnormalities are followed by impairment of liver detoxification ability and liver may be a source of toxins per se. Remaxol infusion in the treatment of experimental and clinical acute peritonitis increased liver tolerance to trigger pathogenetic agents. This process resulted improvement of laboratory and clinical parameters. In general, we obtained high significance of liver damage in pathogenesis of acute urgent abdominal pathology.
Experimental and clinical data for determining hepatic distress syndrome as important aspect in acute abdominal surgical diseases have been obtained. Hepatic distress syndrome in surgery is a combination of abnormal processes with progression of endogenous intoxication, oxidative stress and phospholipase activity following membrane-destabilizing phenomena and secondary liver dysfunction.
确立肝脏疾病的普遍性和规律性、其在体内稳态失衡发病机制中的作用,并为一种新的综合征——外科肝衰综合征确定科学依据。
对杂种犬进行慢性实验。第一组(n = 15)模拟急性腹膜炎,第二组(n = 15)模拟急性坏死性胰腺炎,第三组(n = 15)模拟急性梗阻性肠梗阻。第四组(n = 15)在实验性急性腹膜炎后输注雷马索(20 ml/kg)。使用内源性中毒指标、脂质代谢标志物以及肝组织中的脂质成分评估肝功能。临床研究包括44例腹膜炎患者(第一亚组——标准治疗,n = 20;第二亚组输注雷马索,n = 24)、重症急性胰腺炎患者(n = 18)、急性粘连性肠梗阻患者(n = 20)。患者接受手术治疗。除常规指标外,还分析了内源性中毒的严重程度、脂质过氧化、磷脂酶活性、血脂和红细胞计数。
实验和临床研究表明,所有具有不同发病机制的疾病均存在明显的肝损伤。无论急症如何,主要成分之一是膜稳定性破坏过程。这一过程由肝组织中膜脂质过氧化和磷脂酶的过度活性所决定。严重异常之后是肝脏解毒能力受损,肝脏本身可能成为毒素来源。在实验性和临床急性腹膜炎治疗中输注雷马索可提高肝脏对致病因子的耐受性。这一过程使实验室和临床参数得到改善。总体而言,我们得出肝损伤在急性急腹症发病机制中具有高度重要性。
已获得将肝衰综合征确定为急性腹部外科疾病重要方面的实验和临床数据。外科肝衰综合征是在内源性中毒、氧化应激和磷脂酶活性随着膜稳定性破坏现象及继发性肝功能障碍进展而出现的异常过程的组合。